p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas

Jian-Zhong Qin1, Lawrence Stennett, Patricia Bacon

  • 1Department of Pathology, Loyola University of Chicago Medical Center, Chicago, IL, USA.

Insights

A gamma-secretase inhibitor (GSI) effectively kills melanoma cells by inducing apoptosis through a p53-independent pathway. This novel approach overcomes treatment resistance and spares normal melanocytes, offering new therapeutic targets for advanced melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Metastatic melanoma is notoriously resistant to apoptosis and current therapies.
  • Defects in apoptotic machinery, such as Apaf-1 inactivation, contribute to melanoma's survival.
  • Identifying novel agents to overcome apoptosis resistance is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the efficacy of a gamma-secretase inhibitor (GSI) in inducing apoptosis in melanoma cells.
  • To elucidate the molecular mechanisms by which GSI overcomes melanoma's resistance to cell death.
  • To evaluate the therapeutic potential of GSI as a targeted treatment for melanoma.

Main Methods:

  • Treatment of melanoma cell lines and normal melanocytes with GSI (z-Leu-Leu-Nle-CHO).
  • Assessment of apoptosis induction, cell cycle arrest, and protein synthesis.
  • Analysis of mitochondrial pathways, BH3-only protein (Bim, NOXA) expression, and p53 activation.
  • Validation using antisense oligonucleotides and evaluation in cell lines with varying Apaf-1 levels.

Main Results:

  • GSI induced apoptosis in all tested melanoma lines but only G2-M arrest in normal melanocytes.
  • GSI-mediated killing involved new protein synthesis and a mitochondrial pathway via up-regulation of Bim and NOXA.
  • Apoptosis induction was p53-independent and effective even in melanoma cells with low Apaf-1 levels.
  • Antisense inhibition of NOXA significantly reduced GSI-induced apoptosis.

Conclusions:

  • GSI is a potent agent for selectively killing melanoma cells while sparing normal melanocytes.
  • GSI enhances BH3-only proteins to execute apoptosis, overcoming melanoma's inherent resistance.
  • A p53-independent apoptotic pathway, effective in cells with low Apaf-1, offers new therapeutic targets for chemoresistant tumors.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...